Rlm Consulting

RLM Consulting provides a wide range of regulatory affairs supports for the development of disruptive Investigational Medicinal Products (IMP) and Investigational New Drugs (IND), from early nonclinical development to the late phases of clinical development. We aim to accelerate your journey with the best regulatory pathway in Europe and in the United States of America. Our consultants, all highly skilled in science and regulatory affairs can guide you on the chemistry, manufacturing, control, nonclinical and clinical requirements. We act as an applicant for various submissions, and we write the content of your dossiers.